FDA grants accelerated approval to Breyanzi (lisocabtagene maraleucel) for follicular lymphoma (Catapult's regulatory round-up - May 2024)

On 15 May 2024, the FDA granted accelerated approval to lisocabtagene maraleucel for adults with relapsed or refractory follicular lymphoma (FL) who have received two or more prior lines of systemic therapy. Please find further information here. Published on the 5th of June in Catapult's regulatory round-up for May 2024.

Publication Details

Journal
Industrias Culturais (Universidade de Coimbra)
Published
2024-11-04
DOI
https://doi.org/10.58079/12m75
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FDA grants accelerated approval to Breyanzi (lisocabtagene maraleucel) for follicular lymphoma (Catapult's regulatory round-up - May 2024)

Industrias Culturais (Universidade de Coimbra)
Lymphoma Diagnosis and Treatment
article

FDA grants accelerated approval to Breyanzi (lisocabtagene maraleucel) for follicular lymphoma (Catapult's regulatory round-up - May 2024)

article en

Abstract

On 15 May 2024, the FDA granted accelerated approval to lisocabtagene maraleucel for adults with relapsed or refractory follicular lymphoma (FL) who have received two or more prior lines of systemic therapy. Please find further information here. Published on the 5th of June in Catapult's regulatory round-up for May 2024.

Industrias Culturais (Universidade de Coimbra)
Partnerships for the goals, Good health and well-being
Openalex Percentile: Top 53%
Lymphoma Diagnosis and Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

FDA grants accelerated approval to Breyanzi (lisocabtagene maraleucel) for follicular lymphoma (Catapult's regulatory round-up - May 2024) · Industrias Culturais (Universidade de Coimbra) (2024) | TGRS Research Map | TGRS